Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Derhaschnig

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Haematologica|November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trialKatarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2019
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy VolunteersZoltan Magyarics, Fraser Leslie, Johann Bartko, et al.
Eclinicalmedicine|January 26, 2024
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 resultsChristian Schoergenhofer, Georg Gelbenegger, Dzenita Hasanacevic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 11, 2005
Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency departmentJordi Ordóñez-Llanos, Miquel Santaló-Bel, Javier Mercé-Muntañola, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Haematologica|November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trialKatarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2019
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy VolunteersZoltan Magyarics, Fraser Leslie, Johann Bartko, et al.
Eclinicalmedicine|January 26, 2024
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 resultsChristian Schoergenhofer, Georg Gelbenegger, Dzenita Hasanacevic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 11, 2005
Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency departmentJordi Ordóñez-Llanos, Miquel Santaló-Bel, Javier Mercé-Muntañola, et al.
Pageof 6